Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Accounts Payables (2016 - 2025)

GeoVax Labs' Accounts Payables history spans 16 years, with the latest figure at $790750.0 for Q4 2025.

  • Quarterly results put Accounts Payables at $790750.0 for Q4 2025, down 57.25% from a year ago — trailing twelve months through Dec 2025 was $790750.0 (down 57.25% YoY), and the annual figure for FY2025 was $790750.0, down 57.25%.
  • Accounts Payables for Q4 2025 was $790750.0 at GeoVax Labs, down from $976411.0 in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $4.2 million in Q3 2023 to a low of $232482.0 in Q1 2021.
  • The 5-year median for Accounts Payables is $1.5 million (2022), against an average of $1.6 million.
  • Peak annual rise in Accounts Payables hit 668.59% in 2021, while the deepest fall reached 68.62% in 2021.
  • Year by year, Accounts Payables stood at $2.1 million in 2021, then decreased by 15.06% to $1.7 million in 2022, then skyrocketed by 60.38% to $2.8 million in 2023, then crashed by 34.01% to $1.8 million in 2024, then crashed by 57.25% to $790750.0 in 2025.
  • According to Business Quant data, Accounts Payables over the past three periods came in at $790750.0, $976411.0, and $1.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.